SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

SANKARANARAYANAN, Rengaswamy; BUDUKH, Atul Madhukar  and  RAJKUMAR, Rajamanickam. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ [online]. 2001, vol.79, n.10, pp. 954-962. ISSN 0042-9686.  http://dx.doi.org/10.1590/S0042-96862001001000009.

    1. Walboomers JMM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology, 1999, 51: 268¾275.

    [ Links ]

    2. Ferlay J et al. Globocan 2000. Cancer incidence, mortality and prevalence worldwide, version 1.0. Lyon, International Agency for Research on Cancer, 2001 (IARC Cancer Base No. 5).

    [ Links ]

    3. Coleman M et al. Time trends in cancer incidence and mortality. Lyon, International Agency for Research on Cancer, 1995 (IARC Scientific Publications No. 121).

    [ Links ]

    4. Wabinga H et al. Trends in cancer incidence in Kyadondo County, Uganda, 1960¾1997. British Journal of Cancer, 2000, 82: 585¾1592.

    [ Links ]

    5. Hakama M et al. Evaluation of screening programmes for gynaecological cancer. British Journal of Cancer, 1985, 52: 669¾673.

    [ Links ]

    6. Control of cancer of the uterine cervix. A WHO meeting. Bulletin of the World Health Organization, 1986, 64: 607¾618.

    [ Links ]

    7. Hakama M et al. Screening for cancer of the uterine cervix. Lyon, International Agency for Research on Cancer, 1986 (IARC Scientific Publications No. 76).

    [ Links ]

    8. Miller AB et al. Report on a workshop UICC project on evaluation of screening for cancer. International Journal of Cancer, 1990, 46: 761¾769.

    [ Links ]

    9. Nasiell K et al. Behaviour of mild dysplasia during long-term follow-up. Obstetrics and Gynaecology, 1986, 67: 665¾669.

    [ Links ]

    10. Holowaty P et al. Natural history of dysplasia of the uterine cervix. Journal of the National Cancer Institute, 1999, 91: 252¾ 268.

    [ Links ]

    11. Fahey MT et al. Meta-analysis of Pap test accuracy. American Journal of Epidemiology, 1995, 141: 680¾689.

    [ Links ]

    12. Nanda K et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Annals of Internal Medicine, 2000, 132: 810¾819.

    [ Links ]

    13. Herdman C et al. Planning appropriate cervical cancer prevention programs. Seattle, WA, Program for Appropriate Technology in Health, 2000.

    [ Links ]

    14. Irwin IR et al. Screening practices for cervical and breast cancer in Costa Rica. Bulletin of the Pan American Health Organization, 1991, 25: 16¾26.

    [ Links ]

    15. Herrero R et al. Determinants of geographical variations of cervical cancer in Costa Rica. Bulletin of the Pan American Health Organization, 1993, 27: 15¾25.

    [ Links ]

    16. Sierra R et al. Cancer in Costa Rica. Lyon, International Agency for Research on Cancer, 1988 (IARC Technical Report No. 1).

    [ Links ]

    17. Schiffman et al. HPV DNA testing in cervical cancer screening: results from women in high-risk province of Costa Rica. Journal of the American Medical Association, 2000, 283: 87¾93.

    [ Links ]

    18. Fernandez Garrotte L. Evaluation of the Cervical Cancer Control Program in Cuba. Bulletin of the Pan American Health Organization, 1996, 30, 387¾391.

    [ Links ]

    19. Lazcano-Ponce EC et al. Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach. Cancer Causes Control, 1998, 9: 241¾ 251.

    [ Links ]

    20. Lazcano-Ponce EC et al. Cervical cancer screening in developing countries: Why is it ineffective? The case of Mexico. Archives of Medical Research, 1999, 30: 240¾250.

    [ Links ]

    21. Lazcano-Ponce EC et al. Validity and reproducibility of cytologic diagnosis in a sample of cervical cancer screening centers in Mexico. Acta Cytologica, 1997, 41: 277¾284.

    [ Links ]

    22. Lazcano-Ponce EC et al. Mortality from cervical carcinoma in Mexico: impact of screening, 1980¾1990. Acta Cytologica, 1996, 40: 506¾512.

    [ Links ]

    23. Chokunonga E et al. Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993¾1995. International Journal of Cancer, 2000, 85: 54¾ 59.

    [ Links ]

    24. University of Zimbabwe/JHPIEGO Cervical cancer prevention project. Visual inspection with acetic acid for cervical cancer screening: test qualities in a primary-care setting. Lancet, 1999, 353: 869¾873.

    [ Links ]

    25. Womack SD et al. Evaluation of human papillomavirus assay in cervical screening in Zimbabwe. British Journal of Obstetrics and Gynaecology, 2000, 107: 33¾38.

    [ Links ]

    26. Womack SD et al. HPV-based cervical cancer screening in a population at high risk for HIV infection. International Journal of Cancer, 2000, 85: 206¾210.

    [ Links ]

    27. Blumenthal PD et al. Adjunctive testing for cervical cancer in low- resource settings with visual inspection, HPV, and the Pap smear. International Journal of Gynecology and Obstetrics, 2001, 72: 47¾53.

    [ Links ]

    28. Leiman G. "Project Screen Soweto" ¾ a planned cervical screening programme in a high-risk population. South African Medical Journal, 1987, 2: 61¾68.

    [ Links ]

    29. Denny et al. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer, 2000, 89: 826¾ 833.

    [ Links ]

    30. Wright TC et al. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. Journal of the American Medical Association, 2000, 283: 81¾86.

    [ Links ]

    31. Megevand E et al. Acetic acid visualization of the cervix: an alternative to cytologic screening. Obstetrics and Gynecology, 1996, 88: 383¾386.

    [ Links ]

    32. Goldie SJ et al. Policy analysis of cervical cancer screening strategies in low-resource settings. Clinical benefits and cost effectiveness. Journal of the American Medical Association, 2001, 285: 3107¾3115.

    [ Links ]

    33. Jayant K et al. Improved stage at diagnosis of cervical cancer with increased cancer awareness in a rural Indian population. International Journal of Cancer, 1995, 63: 161¾163.

    [ Links ]

    34. Jayant K et al. Survival from cancer in Barshi registry, rural India. In: Sankaranarayanan R, Black RJ, Parkin DM, eds. Cancer survival in developing countries. Lyon, International Agency for Research on Cancer, 1988: 69¾77 (IARC Scientific Publications No. 145).

    [ Links ]

    35. Parkin DM, Sankaranarayanan R. Prevention of cervical cancer in developing countries. Thai Journal of Obstetrics and Gynaecology, 1999, 11S: 3¾20.

    [ Links ]

    36. Sankaranarayanan R et al. Visual inspection as a screening test for cervical cancer control in developing countries. In: Franco E, Monsonego J, eds. New developments in cervical cancer screening and prevention. Oxford, Blackwell Science, 1997: 411¾421.

    [ Links ]

    37. Sankaranarayanan R et al. Performance of visual inspection after acetic acid application (VIA) in the detection of cervical cancer precursors. Cancer, 1998, 83: 2150¾2156.

    [ Links ]

    38. Sankaranarayanan R et al. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. International Journal of Cancer, 1999, 80: 161¾163.

    [ Links ]

    39. National workshop on control of cervical cancer- alternative strategies. New Delhi, Institute of Cytology and Preventive Oncology, Indian Council of Medical Research, 2001.

    [ Links ]

    40. Hakama M et al., eds. Screening for cancer of the uterine cervix. Lyon, International Agency for Research on Cancer, 1986 (IARC Scientific Publications No. 76).

    [ Links ]

    41. Prabhakar AK. Cervical cancer in India strategy for control. Indian Journal of Cancer, 1992, 104: 29¾32.

    [ Links ]

    42. Murthy NS et al. Estimation of reduction in life-time risk of cervical cancer through one life-time screening. Neoplasma, 1993, 40: 255¾258.

    [ Links ]

    43. Miller AB. Cervical cancer screening programmes ¾ Managerial guidelines. Geneva, World Health Organization, 1992.

    [ Links ]